⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1155848 | 0.64 | — | — | |
| SCHEMBL5888439 | 0.61 | — | — | |
| SCHEMBL12957878 | 0.61 | — | — | |
| SCHEMBL14492362 | 0.61 | — | — | |
| SCHEMBL6249697 | 0.59 | — | — | |
| SCHEMBL28210 | 0.58 | — | — | |
| SCHEMBL12268271 | 0.57 | — | — | |
| SCHEMBL10537127 | 0.57 | — | — | |
| SCHEMBL11392188 | 0.57 | — | — | |
| SCHEMBL25254217 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| EP-3096369-B1 | ORGANIC SOLAR CELL AND METHOD FOR MANUFACTURING SAME | LG CHEMICAL LTD (KR) | 2020-10-14 | — | — | EP | disclosed |
| US-9873691-B2 | TRPV1 antagonists including dihydroxy substituent and uses thereof | PURDUE PHARMA L.P. (US) | 2018-01-23 | — | — | US | disclosed |
| US-20160343956-A1 | ORGANIC SOLAR CELL AND METHOD FOR MANUFACTURING SAME | LG CHEMICAL LTD (KR) | 2016-11-24 | — | — | US | disclosed |
| EP-3096369-A1 | ORGANIC SOLAR CELL AND METHOD FOR MANUFACTURING SAME | LG Chem, Ltd. (KR) | 2016-11-23 | — | — | EP | disclosed |
| US-20160318920-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. | 2016-11-03 | — | — | US | disclosed |
| US-9394293-B2 | TRPV1 antagonists including dihydroxy substituent and uses thereof | PURDUE PHARMA L.P. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20140350056-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. | 2014-11-27 | — | — | US | disclosed |
| WO-2013021276-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. (US) | 2013-02-14 | — | — | WO | disclosed |
| US-8129388-B2 | Therapeutic agents useful for treating pain | Purde Pharma L.P. (US) | 2012-03-06 | — | — | US | disclosed |
| US-20040044003-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-03-04 | — | — | US | disclosed |
| WO-2004011441-A1 | PYRIDAZINYLPIPERAZINE DERIVATIVES FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2004-02-05 | — | — | WO | disclosed |
| EP-1383505-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | Inotek Pharmaceuticals Corporation (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | PURDUE PHARMA L.P. | 2004-01-08 | — | — | US | disclosed |
| WO-2003074520-A1 | THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN | EURO-CELTIQUE, S.A. (LU) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003066595-A2 | 2 - PIPERAZINE - PYRIDINES USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2003-08-14 | — | — | WO | disclosed |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | INOTEK PHARMACEUTICALS CORPORATION | 2003-02-27 | — | — | US | disclosed |
| WO-2002102955-A1 | WATER SOLUBLE PACKAGE AND LIQUID CONTENTS THEREOF | UNILEVER PLC (GB) | 2002-12-27 | — | — | WO | disclosed |
| US-20020198125-A1 | Water soluble package and liquid contents thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-12-26 | — | — | US | disclosed |
| WO-2002076400-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | INOTEK PHARMACEUTICALS CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |